
LEO Pharma Unveils Anzupgo® (delgocitinib) Cream Results at EADV 2024 for Chronic Hand Eczema
LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data from the DELTA FORCE trial at the 33rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam. The company shared six additional abstracts regarding Anzupgo® (delgocitinib)…












